These results claim that, in HCC, FARSB may have a close relation with the m6A modification, specifically via its interactions with LRPPRC, RBM15B, and HNRNPA2B1, all of which eventually influence the progression and prognosis of HCC. This evidence concerns the gene HNRNPA2B1 and hepatocellular carcinoma.